1-5 of 5
Juliane Musacchio, MD PhD
Close
Sort by
Journal Articles

Open-Label Early-Access Programs (EAPs) for Ibrutinib in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL) or Mantle-Cell Lymphoma (MCL)

Carlos Sérgio Chiattone, MD, Nelson Hamerschlak, MD PhD, Laura Fogliatto, Phillip Scheinberg, MD, Ricardo Bigni, MD MPH, Celso Rodrigues, MD PhD, Bernardo Garicochea, Alex Pimenta, Tiago Oliveira Boechat, MD, Juliane Musacchio, MD PhD, Jaisson Bortolini, MD, Iara Zapparoli Goncalves, MD, Garles Miller Matias Vieira, Valeria Buccheri, MD PhD, Telma Santos, Mariana Grings, Lori Parisi, Paula Barreyro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5554.
https://doi.org/10.1182/blood-2018-99-116720
Published: 2018
Journal Articles

Incidence and Impact of Activating Mutations of the RAS-RAF-MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders–Unclassified (MDS/MPD-U)

Fabio PS Santos, MD, Bianca Lisboa, MSc, Tarcila S Datoguia, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Mariana Miyagi, Evelyn HA da Mata, Rodrigo Santucci, MD, Guilherme F Perini, MD, Eizabeth Xisto Souto, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Marcia Higashi, MD, Rodolfo Soares, MD, Adriana Valente Fadel, MD, Juliane Musacchio, MD PhD, Ana Fernandes Schriefer, MD, Marco Aurelio Salvino, MD PhD, Danielle Leao Cordeiro De Farias, MD MSc, Leila Martins Perobelli, MD, Erika MM Costa, MD, Marinus M Lima, Vinicius R. P. Mattos, MD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Joao Carlos Guerra, MD PhD, Alanna Mara P. S Bezerra, MD, Denise da Cunha Pasqualin, MD, Isabel C Bello, RN, Michelli Silva Diniz, RN, Sandra S Nakashima, RN, Elvira Velloso, MD PhD, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD
Journal: Blood
Blood (2014) 124 (21): 3172.
https://doi.org/10.1182/blood.V124.21.3172.3172
Published: 2014
Journal Articles

Genomic Profile of Patients with Triple Negative (JAK2, CALR and MPL) Essential Thrombocythemia and Primary Myelofibrosis

Paulo Vidal Campregher, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Bianca Garcia Lisboa, MSc, Evelyn Helena Ascendino, Mariana Miyagi, Sandra Nakashima Yoshida, Isabel Bello, Michelli Silva Diniz, RN, Guilherme Fleury Perini, MD, Elvira Velloso, MD PhD, Joao Carlos Guerra, MD PhD, Paulo A.A. Silveira, MDPhD, Nydia Bacal, MD, Roberta Cardoso Petroni, Juliane Musacchio, MD PhD, Rodrigo Santucci, MD, Ana Fernandes Schriefer, MD, Marco A. Salvino, MD PhD, Soares Almeida Rodolfo, MD, Manuela Pinto Tibúrcio, Leila Martins Perobelli, MD, Eizabeth Xisto Souto, MD, Danielle Leao Cordeiro De Farias, MD MSc, Marcia Higashi, MD, Adriana Valente Fadel, MD, Tarcila S Datoguia, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Fernando Ferreira Costa, MD PhD, Nelson Hamerschlak, MD PhD, Fabio Pires de Souza Santos, MD
Journal: Blood
Blood (2014) 124 (21): 4589.
https://doi.org/10.1182/blood.V124.21.4589.4589
Published: 2014
Journal Articles

Whole Exome Sequencing of Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders (MDS/MPD)

Fabio P S Santos, MD, Renato D Puga, MSc, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Tarcila S Datoguia, MD, Bianca Lisboa, MSc, Mariana Miyagi, Evelyn HA da Mata, Rodrigo Santucci, MD, Guilherme F Perini, MD, Eizabeth Xisto Souto, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Rodolfo Soares, MD, Marcia Higashi, MD, Adriana Valente Fadel, MD, Juliane Musacchio, MD PhD, Ana Fernandes Schriefer, MD, Marco Aurelio Salvino, MD PhD, Danielle Leao Cordeiro De Farias, MD MSc, Leila Martins Perobelli, MD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Joao Carlos Guerra, MD PhD, Alanna Mara P. S Bezerra, MD, Denise da Cunha Pasqualin, MD, Marinus M Lima, Erika MM Costa, MD, Vinicius R. P. Mattos, MD, Isabel C Bello, RN, Michelli Silva Diniz, RN, Sandra S Nakashima, RN, Elvira Velloso, MD PhD, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD
Journal: Blood
Blood (2014) 124 (21): 4593.
https://doi.org/10.1182/blood.V124.21.4593.4593
Published: 2014
Journal Articles

The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia

Paulo Vidal Campregher, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Bianca Lisboa, MSc, Evelyn Helena Ascendino, Mariana Miyagi, Sandra Nakashima Yoshida, Isabel C Bello, RN, Michelli Silva Diniz, RN, Guilherme Fleury Perini, MD, Tarcila S Datoguia, MD, Elvira Velloso, MD PhD, Joao Carlos Guerra, MD PhD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Roberta Cardoso Petroni, Juliane Musacchio, MD PhD, Rodrigo Santucci, MD, Ana Fernandes Schriefer, MD, Marco A. Salvino, MD PhD, Rodolfo Soares, MD, Manuela Pinto Tibúrcio, Leila Martins Perobelli, MD, Eizabeth Xisto Souto, MD, Danielle Leao Cordeiro De Farias, MD MSc, Marcia Higashi, MD, Adriana Valente Fadel, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Denise da Cunha Pasqualin, MD, Alanna Mara P. S Bezerra, MD, Marinus de Moraes Lima, MD, Erika MM Costa, MD, Vinicius R. P. Mattos, MD, Fernando Ferreira Costa, MD PhD, Nelson Hamerschlak, MD PhD, Fabio Pires de Souza Santos, MD
Journal: Blood
Blood (2014) 124 (21): 4595.
https://doi.org/10.1182/blood.V124.21.4595.4595
Published: 2014